Allergan's sales of eye care pharmaceuticals rose in the second quarter by 13.8 percent to $657.6 million as compared to the same period one year ago, with a rise of 10.1 percent in local currencies. The company's total net product sales rose 13.7 percent to $1,400.4 million, up by 9.6 ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.